血中高胆固醇细胞数量,喘易感性和喘严重程度之间的遗传关系
Huashi Li1,2, Xingnan Li2
1Statistics Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, USA.
概括
血中高血红蛋白细胞计数 (BEC) 与喘风险有关,但与严重程度无关. 喘和BEC的遗传因素不同,在高BEC和喘易感性之间存在双向因果关系.
科学领域:
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 喘的遗传基础,特别是由血中乙氨基酸细胞计数 (BEC) 定义的亚型,仍然不完全理解.
- 研究2型 (T2) 和非2型 (非T2) 喘之间的遗传区别对于理解疾病异质性至关重要.
- 升高的BEC,喘易感性和疾病严重程度之间的关系需要进一步的遗传阐明.
研究的目的:
- 根据BEC水平确定T2和非T2喘之间的遗传差异.
- 调查高BEC,喘易感性和喘严重程度之间的遗传关联.
- 使用孟德尔随机化来确定BEC,喘易感性和严重性之间的因果关系.
主要方法:
- 全基因组关联研究 (GWAS) 在英国生物银行和我们所有人研究计划队列中进行.
- GWAS分析了T2与非T2喘,喘易感性和喘严重程度.
- 孟德尔随机化 (MR) 用于评估BEC,喘易感性和严重性之间的因果关系.
主要成果:
- 确定了四种不同的基因变异组,与BEC,喘或两者相关.
- 在ATXN2中rs653178变异与高BEC,自身免疫疾病风险和喘保护有关.
- 核磁共振分析显示,高BEC和喘易感性之间存在双向因果关系,但喘严重程度并非如此.
结论:
- 影响喘易感性和BEC的遗传因素与影响喘严重性的遗传因素不同.
- 高BEC是喘的重要风险因素,但不是敏感性或严重性的唯一决定因素.
- 独特的遗传结构是喘易感性和严重性的基础,BEC发挥着复杂的作用.
更多相关视频
相关概念视频
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
446
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
446
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


